Normal Production Rate of Apolipoprotein B in LDL Receptor–Deficient Mice
Open Access
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (6) , 989-994
- https://doi.org/10.1161/01.atv.0000018304.30943.06
Abstract
The low density lipoprotein (LDL) receptor is well known for its role in mediating the removal of apolipoprotein B (apoB)-containing lipoproteins from plasma. Results from in vitro studies in primary mouse hepatocytes suggest that the LDL receptor may also have a role in the regulation of very low density lipoprotein (VLDL) production. We conducted in vivo experiments using LDLR −/−, LDLR +/−, and wild-type mice ( LDLR indicates LDL receptor gene) in which the production rate of VLDL was measured after the injection of [ 35 S]methionine and the lipase inhibitor Triton WR1339. Despite the fact that LDLR −/− mice had a 3.7-fold higher total cholesterol level and a 2.1-fold higher triglyceride level than those of the wild-type mice, there was no difference in the production rate of VLDL triglyceride or VLDL apoB between these groups of animals. Experiments were also conducted in apobec1 −/− mice, which make only apoB-100, the form of apoB that binds to the LDL receptor. Interestingly, the apobec1 −/− mice had a significantly higher production rate of apoB than did the wild-type mice. However, despite significant differences in total cholesterol and triglyceride levels, there was no difference in the production rate of total or VLDL triglyceride or VLDL apoB between LDLR −/− and LDLR +/− mice on an apobec1 −/− background. These results indicate that the LDL receptor has no effect on the production rate of VLDL triglyceride or apoB in vivo in mice.Keywords
This publication has 14 references indexed in Scilit:
- Post-transcriptional Stimulation of the Assembly and Secretion of Triglyceride-rich Apolipoprotein B Lipoproteins in a Mouse with Selective Deficiency of Brown Adipose Tissue, Obesity, and Insulin ResistancePublished by Elsevier ,2001
- The Triple Threat to Nascent Apolipoprotein BPublished by Elsevier ,2001
- The role of the LDL receptor in apolipoprotein B secretionJournal of Clinical Investigation, 2000
- Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDLJournal of Clinical Investigation, 1999
- Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnoverThe Journal of Pediatrics, 1988
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.Proceedings of the National Academy of Sciences, 1983
- The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemiaAtherosclerosis, 1982
- Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemiaAtherosclerosis, 1977
- SUSTAINED HYPERLIPEMIA INDUCED IN RABBITS BY MEANS OF INTRAVENOUSLY INJECTED SURFACE-ACTIVE AGENTSThe Journal of Experimental Medicine, 1951